He Xiao, Chen Jiadong, Zhong Yan, Cen Peili, Shen Li, Huang Fei, Wang Jing, Jin Chentao, Zhou Rui, Zhang Xiaohui, Wang Anxin, Fan Jing, Wu Shuang, Tu Mengjiao, Qin Xiyi, Luo Xiaoyun, Zhou Yu, Peng Jieqiao, Zhou Youyou, Civelek A Cahid, Tian Mei, Zhang Hong
Department of Nuclear Medicine, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, 310022, China.
Department of Radiology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, 310006, China.
Nat Commun. 2025 Jun 3;16(1):5132. doi: 10.1038/s41467-025-60187-5.
Human cortical neural progenitor cell transplantation holds significant potential in cortical stroke treatment by replacing lost cortical neurons and repairing damaged brain circuits. However, commonly utilized human cortical neural progenitors are limited in yield a substantial proportion of diverse cortical neurons and require an extended period to achieve functional maturation and synaptic integration, thereby potentially diminishing the optimal therapeutic benefits of cell transplantation for cortical stroke. Here, we generated forkhead box G1 (FOXG1)-positive forebrain progenitors from human inducible pluripotent stem cells, which can differentiate into diverse and balanced cortical neurons including upper- and deep-layer excitatory and inhibitory neurons, achieving early functional maturation simultaneously in vitro. Furthermore, these FOXG1 forebrain progenitor cells demonstrate robust cortical neuronal differentiation, rapid functional maturation and efficient synaptic integration after transplantation into the sensory cortex of stroke-injured adult rats. Notably, we have successfully utilized the non-invasive F-SynVesT-1 PET imaging technique to assess alterations in synapse count before and after transplantation therapy of FOXG1 progenitors in vivo. Moreover, the transplanted FOXG1 progenitors improve sensory and motor function recovery following stroke. These findings provide systematic and compelling evidence for the suitability of these FOXG1 progenitors for neuronal replacement in ischemic cortical stroke.
人类皮质神经祖细胞移植通过替代丢失的皮质神经元和修复受损的脑回路,在皮质中风治疗中具有巨大潜力。然而,常用的人类皮质神经祖细胞在产生大量不同类型的皮质神经元方面存在局限性,并且需要较长时间才能实现功能成熟和突触整合,从而可能降低细胞移植对皮质中风的最佳治疗效果。在此,我们从人类诱导多能干细胞中生成了叉头框G1(FOXG1)阳性的前脑祖细胞,这些细胞可分化为包括上层和深层兴奋性及抑制性神经元在内的多种且平衡的皮质神经元,并在体外同时实现早期功能成熟。此外,这些FOXG1前脑祖细胞在移植到中风损伤的成年大鼠感觉皮质后,表现出强大的皮质神经元分化能力、快速的功能成熟和高效的突触整合。值得注意的是,我们成功利用非侵入性F-SynVesT-1 PET成像技术评估了体内FOXG1祖细胞移植治疗前后突触数量的变化。此外,移植的FOXG1祖细胞可改善中风后的感觉和运动功能恢复。这些发现为这些FOXG1祖细胞适用于缺血性皮质中风的神经元替代提供了系统且有说服力的证据。